SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
BioMidwest
Humanetics Awarded Patent For Drug That Improves The Effectiveness Of Radiation Treatment For Cancer
September 12, 2017
 · 
2 min read
Drug Development
Humanetics To Present Data At Department Of Defense Scientific Meeting
August 22, 2017
 · 
2 min read
BioMidwest
ONL Therapeutics Closes Series A Financing to Support Development of Novel Retinal Cell Protection Platform for Treatment of Ocular Diseases
May 18, 2017
 · 
3 min read
Business
ONL Therapeutics Strengthens Leadership With Addition To Board Of Directors And Expansion Of Operations Team
March 29, 2017
 · 
6 min read
BioMidwest
ONL Therapeutics Receives Nearly $1.0 Million Grant From National Eye Institute For Continued Advancement Of ONL1204 Program
March 21, 2017
 · 
3 min read
BioMidwest
Humanetics Release: Pharma Awarded Patent To Mitigate Erectile Dysfunction Associated With Prostate Cancer Radiotherapy
January 24, 2017
 · 
2 min read
BioMidwest
Humanetics Receives Federal Grant To Further Develop Radiation Countermeasure
August 10, 2016
 · 
3 min read
BioMidwest
ONL Therapeutics Receives Orphan Drug Designation For ONL1204 For Treatment Of Retinal Detachment From FDA
February 11, 2016
 · 
3 min read
BioMidwest
ONL Therapeutics To Present At The 2015 Ophthalmology Innovation Summit At American Academy of Ophthalmology Annual Meeting
October 30, 2015
 · 
3 min read
Business
ONL Therapeutics Announces Formation Of Scientific Advisory Board
October 15, 2015
 · 
6 min read
Load More
JOBS